It is a pharma public limited company based in New Delhi, Delhi, India, established in 2017.
2017 | New Delhi, Delhi, India | ActiveCanaan Lifescience Pharmaceuticals Limited, a active public limited company, was established on 23 October 2017 in New Delhi, Delhi, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U74999DL2017PLC325227. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.30 M and a paid-up capital of ₹0.10 M.
Formerly known as Avon Forever Industries Limited. It upholds a compliant status. Its leadership includes Yogesh Rohidas Lanke (Director), Nagnath Shktishiv Satpute (Director), Abhinav Maheshwari Sohanlal (Director). Past directors included Sunil Bhardwaj, Prasad Bhosale Ashok, Vishakha Prakash Desale. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Rz 201/17, Tughlakabad Extension,, New Delhi, Delhi, 110019.
U74999DL2017PLC325227
325227
23 October 2017
₹0.30 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Canaan Lifescience Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Yogesh Rohidas Lanke | Director | 26 Feb 2021 | Current |
| Nagnath Shktishiv Satpute | Director | 26 Feb 2021 | Current |
| Abhinav Maheshwari Sohanlal | Director | 23 Oct 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 16 Feb 2018 | Past |
| Pramod Abcsdd | Director | 27 Feb 2021 | Past |
| Pramod Abcsdd | Director | 27 Feb 2021 | Past |
| Pramod Abcsdd | Director | 28 Sep 2020 | Past |
| Pramod Abcsdd | Director | 16 Feb 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Canaan Lifescience Pharmaceuticals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12616.52% increase. The company also saw a substantial improvement in profitability, with a 66.48% increase in profit. The company's net worth dipped by a decrease of 6.79%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Canaan Lifescience Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Canaan Lifescience Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Canaan Lifescience Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Canaan Lifescience Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Canaan Lifescience Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Canaan Lifescience Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
Progress on Yogesh Rohidas Lanke was appointed as a Director was appointed as a Director on 26 Feb 2021 & has been associated with this company since 4 years 9 months . was documented.
Progress on Nagnath Shktishiv Satpute was appointed as a Director was appointed as a Director on 26 Feb 2021 & has been associated with this company since 4 years 9 months . was documented.
Abhinav Maheshwari Sohanlal was appointed as a Director was appointed as a Director on 23 Oct 2017 & has been associated with this company since 8 years 1 month . was recorded as a recent event.
Canaan Lifescience Pharmaceuticals Limited was registered on 23 Oct 2017 with Roc Delhi & aged 8 years 1 month as per MCA records. was recorded as a recent event.
The CIN of Canaan Lifescience Pharmaceuticals Limited is U74999DL2017PLC325227.
Canaan Lifescience Pharmaceuticals Limited is headquartered at Rz 201/17, Tughlakabad Extension,, New Delhi, Delhi, 110019.
Canaan Lifescience Pharmaceuticals Limited was incorporated on 23 October 2017.
The current directors of Canaan Lifescience Pharmaceuticals Limited are
The primary industry of Canaan Lifescience Pharmaceuticals Limited is Trade.
Canaan Lifescience Pharmaceuticals Limited is unlisted.
The authorized capital of Canaan Lifescience Pharmaceuticals Limited is ₹0.30 M, and the paid-up capital is ₹0.10 M.
The compliance status of Canaan Lifescience Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX